Daily BriefsIndonesia

Daily Brief Indonesia: Medco Energi, Multi Bintang Indonesia, Bukit Uluwatu Villa and more

In today’s briefing:

  • Lucror Analytics – Morning Views Asia
  • Multi Bintang Indonesia (MLBI IJ) Q3 FY25: Resilient >9% Yield Intact, But No Inflection In Demand
  • Primer: Bukit Uluwatu Villa (BUVA IJ) – Nov 2025


Lucror Analytics – Morning Views Asia

By Leonard Law, CFA

  • In today’s Morning Views publication we comment on developments of the following high yield issuers: Medco Energi
  • UST yields climbed 3-4 bps across the curve yesterday, amid heightened corporate supply after Alphabet Inc issued USD 25 bn of USD- and EUR-denominated bonds. The yield on the 2Y and 10Y UST rose 3 bps each to 3.61% and 4.11%, respectively.
  • Equities climbed, supported by tech stocks after Amazon’s Cloud unit inked a USD 38 bn deal with OpenAI. The S&P 500 edged up 0.2% to 6,852, while the Nasdaq grew 0.5% to 23,835.

Multi Bintang Indonesia (MLBI IJ) Q3 FY25: Resilient >9% Yield Intact, But No Inflection In Demand

By Sameer Taneja

  • Multi Bintang Indonesia (MLBI IJ) reported Q3FY25 YoY revenue/profit declines of 4.3%/5.8%. 9MFY25 revenues/profits were +2%/-5% YoY, due to a slight decrease in margins. 
  • After a strong recovery in demand of 10% YoY in Q2, demand in Q3 was subdued at -4.3% YoY despite more substantial tourism numbers (10% YoY in Q3FY25, 12% Ytd)
  • The stock trades at 10.7x FY25 PE, offers a 9.4% dividend yield, is net cash, and has a substantial ROCE of >70%. 

Primer: Bukit Uluwatu Villa (BUVA IJ) – Nov 2025

By αSK

  • Poised for a Cyclical Upswing: As a pure-play operator of luxury villas and hotels in Bali, BUVA is a direct beneficiary of the robust recovery and positive outlook for Indonesian tourism. International arrivals are projected to continue growing, driving demand for high-end accommodation.
  • Operational Turnaround Amid Financial Volatility: The company has demonstrated a significant revenue recovery post-pandemic, with a 3-year revenue CAGR of 79.5%. However, profitability remains volatile, as evidenced by significant net losses in 2022 and certain quarters of 2023/2024, highlighting operational gearing and sensitivity to occupancy rates.
  • Stretched Valuation and No Yield: The stock trades at a premium valuation with a P/E ratio of 141.3x. This expensive multiple, combined with a long-term history of negative market cap growth and a consistent no-dividend policy, suggests the market has priced in a significant portion of the anticipated recovery.

This content is AI-generated and displayed for general informational purposes only. Please verify independently before use.


💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars